Tesaro, inc. (TSRO)
CashFlow / TTM
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Operating activities
Net loss

-648,620

-536,809

-522,217

-496,126

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-293,882

-

-223,584

-193,224

-169,718

-171,012

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Acquired in-process research and development

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

24,900

0

0

0

Depreciation and amortization expense

9,577

9,696

11,031

9,530

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization expense

-

-

-

-

-

-

-

-

-

-

1,671

-

0

0

0

-

-

-

-

Depreciation expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Stock-based compensation expense

102,796

103,054

98,153

90,426

81,316

69,218

57,395

48,455

42,468

37,679

31,455

25,914

20,655

15,424

13,065

11,683

0

0

0

Non-cash interest expense

13,623

12,875

12,289

11,734

11,346

11,040

10,735

10,450

10,164

9,898

9,632

9,360

0

0

0

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-80

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

19,587

12,703

37,981

47,134

9,568

21,740

6,061

3,634

0

0

0

-

-

-

-

-

-

-

-

Inventories

78,788

87,323

75,989

59,968

38,364

13,278

8,887

13,594

0

0

0

-

-

-

-

-

-

-

-

Other assets

4,170

6,521

21,600

20,214

15,634

16,608

10,459

7,770

5,507

4,615

3,943

3,639

2,207

-661

-1,775

-2,327

0

0

0

Accounts payable

22,193

12,888

-5,260

-1,036

2,623

-13,840

-2,009

-2,835

-2,333

5,480

6,681

1,924

1,465

5,543

3,270

4,220

0

0

0

Accrued expenses

43,640

62,249

77,850

80,837

65,643

45,136

26,126

31,896

19,063

18,777

22,723

20,077

15,842

8,000

5,176

6,209

0

0

0

Deferred revenues

350

256

-74

134

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Other liabilities

6,153

7,787

3,896

4,966

2,951

1,366

-83

1,223

-2,142

39

73

121

3,044

1,559

3,052

1,510

0

0

0

Net cash used in operating activities

-550,730

-414,821

-433,172

-400,121

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Investing activities
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-221,847

-

-167,810

-146,826

-130,646

-117,485

0

0

0

Acquisition of product candidates, technology licenses and milestone payments

-

-

-

-

-

-

-

18,940

0

0

0

-

-

-

-

24,900

0

0

0

Purchase of property and equipment

4,809

4,841

5,807

5,978

6,001

6,614

4,305

2,895

2,256

1,952

2,513

2,305

1,911

1,009

579

1,011

0

0

0

Net cash provided by (used in) investing activities

11,656

-23,376

-66,342

-66,513

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Financing activities
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-24,013

-

-9,911

-8,009

-8,479

-25,911

0

0

0

Proceeds from sale of common stock, net of issuance costs

-

-

-

-8

224,178

633,122

683,119

838,099

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and Employee Stock Purchase Plan

12,604

16,738

30,893

29,719

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

502,200

506,334

324,489

323,307

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Proceeds from exercise of stock options

-

-

-

-

-

-

-

-

-

-

5,770

-

4,926

4,140

3,951

1,663

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

161,174

-

184,327

358,116

357,986

269,947

0

0

0

Decrease in cash, cash equivalents, and restricted cash

-39,236

66,317

-173,874

-142,782

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

Increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

6,606

203,281

218,861

126,551

0

0

0

Non-cash investing and financing activities
Common stock issuance costs - cash not paid as of period end

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Stock option exercise proceeds receivable as of period end

-

-

-

-

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

Leasehold improvement assets funded by lessor

-

-

-

585

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of property and equipment - cash not paid as of period end

-

-

-205

40

0

0

0

-

-

-

-

-

-

-

-

-

-

-

0

Supplemental disclosure of cash flow information
Cash paid for interest

33,099

23,112

15,293

6,038

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes paid

1,026

526

477

573

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-